{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:17:05Z","timestamp":1790925425607,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["16102919"],"award-info":[{"award-number":["16102919"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["T12-704\/16-R"],"award-info":[{"award-number":["T12-704\/16-R"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","award":["ITCPD\/17-9"],"award-info":[{"award-number":["ITCPD\/17-9"]}],"id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The anti-apoptotic MCL1 is critical for delaying apoptosis during mitotic arrest. MCL1 is degraded progressively during mitotic arrest, removing its anti-apoptotic function. We found that knockout of components of ubiquitin ligases including APC\/C, SCF complexes, and the mitochondrial ubiquitin ligase MARCH5 did not prevent mitotic degradation of MCL1. Nevertheless, MARCH5 determined the initial level of MCL1\u2013NOXA network upon mitotic entry and hence the window of time during MCL1 was present during mitotic arrest. Paradoxically, although knockout of MARCH5 elevated mitotic MCL1, mitotic apoptosis was in fact enhanced in a BAK-dependent manner. Mitotic apoptosis was accelerated after MARCH5 was ablated in both the presence and absence of MCL1. Cell death was not altered after disrupting other MARCH5-regulated BCL2 family members including NOXA, BIM, and BID. Disruption of the mitochondrial fission factor DRP1, however, reduced mitotic apoptosis in MARCH5-disrupted cells. These data suggest that MARCH5 regulates mitotic apoptosis through MCL1-independent mechanisms including mitochondrial maintenance that can overcome the stabilization of MCL1.<\/jats:p>","DOI":"10.1038\/s41418-022-01080-2","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T12:03:12Z","timestamp":1667476992000},"page":"753-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["MARCH5 regulates mitotic apoptosis through MCL1-dependent and independent mechanisms"],"prefix":"10.1038","volume":"30","author":[{"given":"Yang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5571-6231","authenticated-orcid":false,"given":"Randy Y. C.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"1080_CR1","doi-asserted-by":"crossref","unstructured":"Poon RY. Mitotic catastrophe. In: Bradshaw R, Stahl P. editors. Encyclopedia of cell biology. Academic Press, San Diego, 2016. p. 399\u2013403.","DOI":"10.1016\/B978-0-12-394447-4.30053-0"},{"key":"1080_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev.cellbio.041408.115949","volume":"24","author":"JA Pesin","year":"2008","unstructured":"Pesin JA, Orr-Weaver TL. Regulation of APC\/C activators in mitosis and meiosis. Annu Rev Cell Dev Biol. 2008;24:475\u201399.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1080_CR3","doi-asserted-by":"publisher","first-page":"R1002","DOI":"10.1016\/j.cub.2015.08.051","volume":"25","author":"A Musacchio","year":"2015","unstructured":"Musacchio A. The molecular biology of spindle assembly checkpoint signaling dynamics. Curr Biol. 2015;25:R1002\u201318.","journal-title":"Curr Biol"},{"key":"1080_CR4","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1242\/jcs.039719","volume":"122","author":"KE Gascoigne","year":"2009","unstructured":"Gascoigne KE, Taylor SS. How do anti-mitotic drugs kill cancer cells? J Cell Sci. 2009;122:2579\u201385.","journal-title":"J Cell Sci"},{"key":"1080_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccr.2008.07.002","volume":"14","author":"KE Gascoigne","year":"2008","unstructured":"Gascoigne KE, Taylor SS. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell. 2008;14:111\u201322.","journal-title":"Cancer Cell"},{"key":"1080_CR6","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1038\/s41388-020-1187-6","volume":"39","author":"TM Lok","year":"2020","unstructured":"Lok TM, Wang Y, Xu WK, Xie S, Ma HT, Poon RYC. Mitotic slippage is determined by p31comet and the weakening of the spindle-assembly checkpoint. Oncogene. 2020;39:2819\u201334.","journal-title":"Oncogene"},{"key":"1080_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15:49\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1080_CR8","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.18632\/oncotarget.6894","volume":"7","author":"O Sloss","year":"2016","unstructured":"Sloss O, Topham C, Diez M, Taylor S. Mcl-1 dynamics influence mitotic slippage and death in mitosis. Oncotarget. 2016;7:5176\u201392.","journal-title":"Oncotarget"},{"key":"1080_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7891","volume":"6","author":"MD Haschka","year":"2015","unstructured":"Haschka MD, Soratroi C, Kirschnek S, H\u00e4cker G, Hilbe R, Geley S, et al. The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest. Nat Commun. 2015;6:6891.","journal-title":"Nat Commun"},{"key":"1080_CR10","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1128\/MCB.00620-06","volume":"27","author":"Q Ding","year":"2007","unstructured":"Ding Q, He X, Hsu JM, Xia W, Chen CT, Li LY, et al. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol Cell Biol. 2007;27:4006\u201317.","journal-title":"Mol Cell Biol"},{"key":"1080_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.18632\/oncotarget.242","volume":"2","author":"H Inuzuka","year":"2011","unstructured":"Inuzuka H, Fukushima H, Shaik S, Liu P, Lau AW, Wei W. Mcl-1 ubiquitination and destruction. Oncotarget. 2011;2:239\u201344.","journal-title":"Oncotarget"},{"key":"1080_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature09779","volume":"471","author":"IE Wertz","year":"2011","unstructured":"Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ, et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature. 2011;471:110\u20134.","journal-title":"Nature"},{"key":"1080_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/cdd.2012.124","volume":"20","author":"MM Magiera","year":"2013","unstructured":"Magiera MM, Mora S, Mojsa B, Robbins I, Lassot I, Desagher S. Trim17-mediated ubiquitination and degradation of Mcl-1 initiate apoptosis in neurons. Cell Death Differ. 2013;20:281\u201392.","journal-title":"Cell Death Differ"},{"key":"1080_CR14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.cell.2005.06.009","volume":"121","author":"Q Zhong","year":"2005","unstructured":"Zhong Q, Gao W, Du F, Wang X. Mule\/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell. 2005;121:1085\u201395.","journal-title":"Cell"},{"key":"1080_CR15","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1158\/0008-5472.CAN-10-4336","volume":"71","author":"J Shi","year":"2011","unstructured":"Shi J, Zhou Y, Huang HC, Mitchison TJ. Navitoclax (ABT-263) accelerates apoptosis during drug-induced mitotic arrest by antagonizing Bcl-xL. Cancer Res. 2011;71:4518\u201326.","journal-title":"Cancer Res"},{"key":"1080_CR16","doi-asserted-by":"crossref","unstructured":"Allan LA, Skowyra A, Rogers KI, Zeller D, Clarke PR. Atypical APC\/C-dependent degradation of Mcl-1 provides an apoptotic timer during mitotic arrest. EMBO J. 2018;37:e96831.","DOI":"10.15252\/embj.201796831"},{"key":"1080_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.15252\/embr.201643309","volume":"18","author":"Z Chen","year":"2017","unstructured":"Chen Z, Liu L, Cheng Q, Li Y, Wu H, Zhang W, et al. Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy. EMBO Rep. 2017;18:495\u2013509.","journal-title":"EMBO Rep"},{"key":"1080_CR18","doi-asserted-by":"publisher","first-page":"10300","DOI":"10.1074\/jbc.RA118.006302","volume":"294","author":"F Koyano","year":"2019","unstructured":"Koyano F, Yamano K, Kosako H, Tanaka K, Matsuda N. Parkin recruitment to impaired mitochondria for nonselective ubiquitylation is facilitated by MITOL. J Biol Chem. 2019;294:10300\u201314.","journal-title":"J Biol Chem"},{"key":"1080_CR19","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1038\/sj.emboj.7601249","volume":"25","author":"R Yonashiro","year":"2006","unstructured":"Yonashiro R, Ishido S, Kyo S, Fukuda T, Goto E, Matsuki Y, et al. A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. EMBO J. 2006;25:3618\u201326.","journal-title":"EMBO J"},{"key":"1080_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1091\/mbc.e15-09-0678","volume":"27","author":"S Xu","year":"2016","unstructured":"Xu S, Cherok E, Das S, Li S, Roelofs BA, Ge SX, et al. Mitochondrial E3 ubiquitin ligase MARCH5 controls mitochondrial fission and cell sensitivity to stress-induced apoptosis through regulation of MiD49 protein. Mol Biol Cell. 2016;27:349\u201359.","journal-title":"Mol Biol Cell"},{"key":"1080_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1091\/mbc.e16-04-0208","volume":"28","author":"E Cherok","year":"2017","unstructured":"Cherok E, Xu S, Li S, Das S, Meltzer WA, Zalzman M, et al. Novel regulatory roles of Mff and Drp1 in E3 ubiquitin ligase MARCH5-dependent degradation of MiD49 and Mcl1 and control of mitochondrial dynamics. Mol Biol Cell. 2017;28:396\u2013410.","journal-title":"Mol Biol Cell"},{"key":"1080_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.142","volume":"5","author":"YY Park","year":"2014","unstructured":"Park YY, Nguyen OT, Kang H, Cho H. MARCH5-mediated quality control on acetylated Mfn1 facilitates mitochondrial homeostasis and cell survival. Cell Death Dis. 2014;5:e1172.","journal-title":"Cell Death Dis"},{"key":"1080_CR23","doi-asserted-by":"publisher","first-page":"15986","DOI":"10.18632\/oncotarget.7558","volume":"7","author":"A Subramanian","year":"2016","unstructured":"Subramanian A, Andronache A, Li YC, Wade M. Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA. Oncotarget. 2016;7:15986\u20136002.","journal-title":"Oncotarget"},{"key":"1080_CR24","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1038\/s41418-020-0517-0","volume":"27","author":"TM Djajawi","year":"2020","unstructured":"Djajawi TM, Liu L, Gong JN, Huang AS, Luo MJ, Xu Z, et al. MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex. Cell Death Differ. 2020;27:2484\u201399.","journal-title":"Cell Death Differ"},{"key":"1080_CR25","doi-asserted-by":"crossref","unstructured":"Arai S, Varkaris A, Nouri M, Chen S, Xie L, Balk SP. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. Elife. 2020;9:e54954.","DOI":"10.7554\/eLife.54954"},{"key":"1080_CR26","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s41418-020-0503-6","volume":"27","author":"MD Haschka","year":"2020","unstructured":"Haschka MD, Karbon G, Soratroi C, O\u2019Neill KL, Luo X, Villunger A. MARCH5-dependent degradation of MCL1\/NOXA complexes defines susceptibility to antimitotic drug treatment. Cell Death Differ. 2020;27:2297\u2013312.","journal-title":"Cell Death Differ"},{"key":"1080_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1083\/jcb.201001083","volume":"190","author":"B Di Fiore","year":"2010","unstructured":"Di Fiore B, Pines J. How cyclin A destruction escapes the spindle assembly checkpoint. J Cell Biol. 2010;190:501\u20139.","journal-title":"J Cell Biol"},{"key":"1080_CR28","doi-asserted-by":"crossref","unstructured":"Yeung TK, Lau HW, Ma HT, Poon RYC. One-step multiplex toolkit for efficient generation of conditional gene silencing human cell lines. Mol Biol Cell. 2021; 32:1320\u201330.","DOI":"10.1091\/mbc.E21-02-0051"},{"key":"1080_CR29","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1038\/sj.onc.1208614","volume":"24","author":"XL Ang","year":"2005","unstructured":"Ang XL, Wade Harper J. SCF-mediated protein degradation and cell cycle control. Oncogene. 2005;24:2860\u201370.","journal-title":"Oncogene"},{"key":"1080_CR30","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1073\/pnas.0701297104","volume":"104","author":"PE Czabotar","year":"2007","unstructured":"Czabotar PE, Lee EF, van Delft MF, Day CL, Smith BJ, Huang DC, et al. Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci USA 2007;104:6217\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1080_CR31","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1101\/gad.1304105","volume":"19","author":"SN Willis","year":"2005","unstructured":"Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005;19:1294\u2013305.","journal-title":"Genes Dev"},{"key":"1080_CR32","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.1016\/j.febslet.2005.09.028","volume":"579","author":"MR Warr","year":"2005","unstructured":"Warr MR, Acoca S, Liu Z, Germain M, Watson M, Blanchette M, et al. BH3-ligand regulates access of MCL-1 to its E3 ligase. FEBS Lett. 2005;579:5603\u20138.","journal-title":"FEBS Lett"},{"key":"1080_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1083\/jcb.200611064","volume":"178","author":"M Karbowski","year":"2007","unstructured":"Karbowski M, Neutzner A, Youle RJ. The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J Cell Biol. 2007;178:71\u201384.","journal-title":"J Cell Biol"},{"key":"1080_CR34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/sj.embor.7400790","volume":"7","author":"N Nakamura","year":"2006","unstructured":"Nakamura N, Kimura Y, Tokuda M, Honda S, Hirose S. MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep. 2006;7:1019\u201322.","journal-title":"EMBO Rep"},{"key":"1080_CR35","doi-asserted-by":"publisher","first-page":"e108587","DOI":"10.15252\/embj.2021108587","volume":"41","author":"A Jenner","year":"2022","unstructured":"Jenner A, Pe\u00f1a-Blanco A, Salvador-Gallego R, Ugarte-Uribe B, Zollo C, Ganief T, et al. DRP1 interacts directly with BAX to induce its activation and apoptosis. EMBO J. 2022;41:e108587.","journal-title":"EMBO J"},{"key":"1080_CR36","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.cell.2010.08.017","volume":"142","author":"S Montessuit","year":"2010","unstructured":"Montessuit S, Somasekharan SP, Terrones O, Lucken-Ardjomande S, Herzig S, Schwarzenbacher R, et al. Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. Cell. 2010;142:889\u2013901.","journal-title":"Cell"},{"key":"1080_CR37","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1038\/s41418-020-0527-y","volume":"27","author":"A Pe\u00f1a-Blanco","year":"2020","unstructured":"Pe\u00f1a-Blanco A, Haschka MD, Jenner A, Zuleger T, Proikas-Cezanne T, Villunger A, et al. Drp1 modulates mitochondrial stress responses to mitotic arrest. Cell Death Differ. 2020;27:2620\u201334.","journal-title":"Cell Death Differ"},{"key":"1080_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1083\/jcb.200708096","volume":"180","author":"EF Lee","year":"2008","unstructured":"Lee EF, Czabotar PE, van Delft MF, Michalak EM, Boyle MJ, Willis SN, et al. A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation. J Cell Biol. 2008;180:341\u201355.","journal-title":"J Cell Biol"},{"key":"1080_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"ICGC\/TCGA P-CAOWGC.","year":"2020","unstructured":"ICGC\/TCGA P-CAOWGC. Pan-cancer analysis of whole genomes. Nature. 2020;578:82\u201393.","journal-title":"Nature"},{"key":"1080_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2017.1283032","volume":"58","author":"P Bose","year":"2017","unstructured":"Bose P, Gandhi V, Konopleva M. Pathways and mechanisms of venetoclax resistance. Leuk Lymphoma. 2017;58:1\u201317.","journal-title":"Leuk Lymphoma"},{"key":"1080_CR41","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1128\/MCB.00669-09","volume":"29","author":"HT Ma","year":"2009","unstructured":"Ma HT, Tsang YH, Marxer M, Poon RY. Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex\/cyclosome axis to promote genome reduplication in the absence of mitosis. Mol Cell Biol. 2009;29:6500\u201314.","journal-title":"Mol Cell Biol"},{"key":"1080_CR42","doi-asserted-by":"publisher","first-page":"109808","DOI":"10.1016\/j.celrep.2021.109808","volume":"37","author":"HW Lau","year":"2021","unstructured":"Lau HW, Ma HT, Yeung TK, Tam MY, Zheng D, Chu SK, et al. Quantitative differences between cyclin-dependent kinases underlie the unique functions of CDK1 in human cells. Cell Rep. 2021;37:109808.","journal-title":"Cell Rep"},{"key":"1080_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-015-0162-8","volume":"15","author":"K Motohashi","year":"2015","unstructured":"Motohashi K. A simple and efficient seamless DNA cloning method using SLiCE from Escherichia coli laboratory strains and its application to SLiP site-directed mutagenesis. BMC Biotechnol. 2015;15:47.","journal-title":"BMC Biotechnol"},{"key":"1080_CR44","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1074\/jbc.275.5.3158","volume":"275","author":"CH Yam","year":"2000","unstructured":"Yam CH, Siu WY, Lau A, Poon RY. Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2. J Biol Chem. 2000;275:3158\u201367.","journal-title":"J Biol Chem"},{"key":"1080_CR45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1128\/MCB.19.1.635","volume":"19","author":"CH Yam","year":"1999","unstructured":"Yam CH, Ng RW, Siu WY, Lau AW, Poon RY. Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2. Mol Cell Biol. 1999;19:635\u201345.","journal-title":"Mol Cell Biol"},{"key":"1080_CR46","doi-asserted-by":"publisher","first-page":"38718","DOI":"10.18632\/oncotarget.9586","volume":"7","author":"S Huang","year":"2016","unstructured":"Huang S, Tang R, Poon RY. BCL-W is a regulator of microtubule inhibitor-induced mitotic cell death. Oncotarget. 2016;7:38718\u201330.","journal-title":"Oncotarget"},{"key":"1080_CR47","unstructured":"Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al. Current protocols in molecular biology. John Wiley & Sons, New York, 1995."},{"key":"1080_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-4939-6603-5_12","volume":"1524","author":"HT Ma","year":"2017","unstructured":"Ma HT, Poon RY. Synchronization of HeLa Cells. Methods Mol Biol. 2017;1524:189\u2013201.","journal-title":"Methods Mol Biol"},{"key":"1080_CR49","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/15384101.2018.1563395","volume":"18","author":"LY Ng","year":"2019","unstructured":"Ng LY, Ma HT, Liu JCY, Huang X, Lee N, Poon RYC. Conditional gene inactivation by combining tetracycline-mediated transcriptional repression and auxin-inducible degron-mediated degradation. Cell Cycle. 2019;18:238\u201348.","journal-title":"Cell Cycle"},{"key":"1080_CR50","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1152\/ajpendo.00457.2019","volume":"318","author":"A Chaudhry","year":"2020","unstructured":"Chaudhry A, Shi R, Luciani DS. A pipeline for multidimensional confocal analysis of mitochondrial morphology, function, and dynamics in pancreatic \u03b2-cells. Am J Physiol Endocrinol Metab. 2020;318:E87\u2013101.","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-022-01080-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-022-01080-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-022-01080-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T16:04:34Z","timestamp":1677859474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-022-01080-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1080"],"URL":"https:\/\/doi.org\/10.1038\/s41418-022-01080-2","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}